COVID-19: Caring for Patients and Communities
The ECRI Institute’s annual Top 10 list of health technology hazards leads off with the complexity of managing medical devices that received emergency use authorization (EUA) during the COVID-19 pandemic.
Last week, the Department of Health and Human Services (HHS) expanded the categories of clinicians authorized to prescribe, dispense and administer COVID-19 vaccines.
Johnson & Johnson Innovation – JLABS, together with AONL and the Society of Nurse Scientists, Innovators, Entrepreneurs, & Leaders (SONSIEL), announced this week that IsoPouch and Pain Rehabilitation Virtual Reality (PR-VR) have been selected as the awardees in the Johnson & Johnson…
The National Institutes of Health (NIH) will collect clinical information on neurological symptoms, complications and outcomes related to COVID-19 through an online data portal created and maintained by NYU Langone Health in New York City.
Data released this week by Eli Lilly showed treatment with a combination of the company’s COVID-19 neutralizing antibodies bamlanivimab and etesevimab reduced the risk of COVID-19 hospitalizations and deaths by 70% among a group of more than 1,000 high-risk patients enrolled in a Phase 3 clinical…
In recent interviews, nurse leaders said collaboration among team members is more important than ever with COVID-19 elevating the risk of burnout.
The American Association of Colleges of Nursing (AACN) announced the launch of a national campaign to accelerate the engagement of nursing schools in efforts to vaccinate the public against COVID-19.
An analysis of state and federal health data showed Black Americans receiving COVID-19 vaccinations at “dramatically lower” rates than their white counterparts
AONL is seeking to identify new models of care and innovations related to staffing and patient care delivery that were introduced to help nurse leaders meet
In a study of 792 patients in six countries, the addition of intravenous arthritis drugs to standard care for COVID-19 patients in intensive care reduced the relative risk of death by 24%.